Fake Drugs Worth ₹ 27.91 Lakh Sent Back To Baddi From Agra, Seized

Solan : A consignment of spurious drugs having a face value of ₹ 27,91,445, manufactured by Baddi-based Trizal Formulation in the name of three renowned companies, was sent back to Baddi by a transport company from Agra following the directions of local drugs officials.

The drugs in 12 boxes had been couriered by kingpin of the spurious drug racket Mohit Bansal on November 21, a day before his arrest, to his wholesale firm MH Pharma in Agra. The officials today seized the consignment from the godown of the transport company TCI in Baddi, said State Drugs Controller Navneet Marwaha.

The Drugs Control Administration (DCA) had alerted the Uttar Pradesh DCA about this consignment on December 1. The consignment had remained undelivered as Bansal’s firm was sealed after the spurious drug racket was detected. The drugs were lying with the TCI in Agra.

“The recovered drugs comprise 1,77, 300 spurious tablets of different brands — Montair- 10, Roseday-10 and Glimisave-M2 tablets. The transport agency was directed to return the consignment as it purportedly contained spurious drugs. Two Drugs Inspectors escorted the transport vehicle from Agra to Baddi to avoid any tampering.”

Marwaha added that the arrest of the accused and timely action against the wholesale firm at Agra by the HP Drugs Control Department prevented the sale of spurious tablets.

The seized drugs comprise drugs used for common ailments. Roseday-10 is used to lower cholesterol, Glimisave-M2 is an anti-diabetic drug and Montair-10 is used by asthma patients. These carried the name of leading companies like Cipla, Eris and USV Private Limited.

Bansal was arrested with a cache of spurious drugs in his car on November 22 near the inter-state barrier at Baddi along with his two associates Atul Gupta and Vijay Kaushal.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India